Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Self-reported adherence by MARS-CZ reflects LDL cholesterol goal achievement among statin users: validation study in the Czech Republic

K. Ladova, P. Matoulkova, Z. Zadak, K. Macek, P. Vyroubal, J. Vlcek, DE. Morisky,

. 2014 ; 20 (5) : 671-7.

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc15023339

RATIONALE, AIMS AND OBJECTIVES: Measuring self-reported adherence may contribute to minimizing the risk of therapy failure. Hence, the main aim of the study was to assess the psychometric properties of the Czech version of Medication Adherence Report Scale (MARS-CZ) and its appropriateness for use in long-term statin therapy where goal levels of low-density lipoprotein cholesterol (LDL-c) should be achieved. METHODS: Anonymous structured interview was performed to determine self-reported adherence by MARS-CZ in outpatients chronically treated with statins. At the same time, medication records were reviewed for inclusion of patients into groups of those who achieved and do not achieved LDL-c goal according to cardiovascular risk level. Reliability and validity of MARS-CZ were tested as well as the relationship between adherence and LDL-c goal achievement was examined. RESULTS: A total of 136 (86.6%) patients completed the interview; mean age was 66.1 years; 49.3% were male. The mean score of MARS-CZ was 24.4 and showed positive skewing. Satisfactory internal consistency (Cronbach's α=0.54), strong test-retest reliability (r=0.83, P<0.001; intra-class correlation=0.63, 95% confidence interval: 0.35-0.81) and positive correlation with eight-item Morisky Medication Adherence Scale (r=0.62, P<0.001) were indicated. Low validity values were found between MARS-CZ and 12-item Short Form Health Survey mental and physical subscales. MARS-CZ score significantly correlated with LDL-c goal achievement (P<0.05) when all patients who achieved LDL-c goal (35%) reported high adherence to statin. MARS-CZ score also correlated with cardiovascular risk level and doctor's judgments on adjusting treatment targets for each patient. CONCLUSION: This study proved MARS-CZ as an acceptable self-reported adherence measure. In routine clinical practice, MARS-CZ could be helpful to reveal medication non-adherence before the alteration of drug regimen and thereby contributing to enhancement of statin therapy management.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15023339
003      
CZ-PrNML
005      
20180117093951.0
007      
ta
008      
150709s2014 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/jep.12201 $2 doi
035    __
$a (PubMed)24917035
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Malá-Ládová, Kateřina $u Department of Social and Clinical Pharmacy, Charles University in Prague, Faculty of Pharmacy in Hradec Kralove, Hradec Kralove, Czech Republic. $7 xx0220369
245    10
$a Self-reported adherence by MARS-CZ reflects LDL cholesterol goal achievement among statin users: validation study in the Czech Republic / $c K. Ladova, P. Matoulkova, Z. Zadak, K. Macek, P. Vyroubal, J. Vlcek, DE. Morisky,
520    9_
$a RATIONALE, AIMS AND OBJECTIVES: Measuring self-reported adherence may contribute to minimizing the risk of therapy failure. Hence, the main aim of the study was to assess the psychometric properties of the Czech version of Medication Adherence Report Scale (MARS-CZ) and its appropriateness for use in long-term statin therapy where goal levels of low-density lipoprotein cholesterol (LDL-c) should be achieved. METHODS: Anonymous structured interview was performed to determine self-reported adherence by MARS-CZ in outpatients chronically treated with statins. At the same time, medication records were reviewed for inclusion of patients into groups of those who achieved and do not achieved LDL-c goal according to cardiovascular risk level. Reliability and validity of MARS-CZ were tested as well as the relationship between adherence and LDL-c goal achievement was examined. RESULTS: A total of 136 (86.6%) patients completed the interview; mean age was 66.1 years; 49.3% were male. The mean score of MARS-CZ was 24.4 and showed positive skewing. Satisfactory internal consistency (Cronbach's α=0.54), strong test-retest reliability (r=0.83, P<0.001; intra-class correlation=0.63, 95% confidence interval: 0.35-0.81) and positive correlation with eight-item Morisky Medication Adherence Scale (r=0.62, P<0.001) were indicated. Low validity values were found between MARS-CZ and 12-item Short Form Health Survey mental and physical subscales. MARS-CZ score significantly correlated with LDL-c goal achievement (P<0.05) when all patients who achieved LDL-c goal (35%) reported high adherence to statin. MARS-CZ score also correlated with cardiovascular risk level and doctor's judgments on adjusting treatment targets for each patient. CONCLUSION: This study proved MARS-CZ as an acceptable self-reported adherence measure. In routine clinical practice, MARS-CZ could be helpful to reveal medication non-adherence before the alteration of drug regimen and thereby contributing to enhancement of statin therapy management.
650    _2
$a senioři $7 D000368
650    _2
$a LDL-cholesterol $x účinky léků $7 D008078
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a cíle $7 D006040
650    _2
$a zdravé chování $7 D015438
650    _2
$a lidé $7 D006801
650    _2
$a statiny $x aplikace a dávkování $x terapeutické užití $7 D019161
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a adherence k farmakoterapii $x psychologie $x statistika a číselné údaje $7 D055118
650    _2
$a lidé středního věku $7 D008875
650    _2
$a psychometrie $7 D011594
650    _2
$a reprodukovatelnost výsledků $7 D015203
650    _2
$a rizikové faktory $7 D012307
650    12
$a zpráva o sobě $7 D057566
650    _2
$a socioekonomické faktory $7 D012959
651    _2
$a Česká republika $7 D018153
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Matoulkova, Petra
700    1_
$a Zadak, Zdenek
700    1_
$a Macek, Karel
700    1_
$a Vyroubal, Pavel, $d 1967- $7 xx0080779
700    1_
$a Vlcek, Jiri
700    1_
$a Morisky, Donald E
773    0_
$w MED00006122 $t Journal of evaluation in clinical practice $x 1365-2753 $g Roč. 20, č. 5 (2014), s. 671-7
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24917035 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150709 $b ABA008
991    __
$a 20180117094226 $b ABA008
999    __
$a ok $b bmc $g 1083677 $s 906332
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 20 $c 5 $d 671-7 $i 1365-2753 $m Journal of evaluation in clinical practice $n J Eval Clin Pract $x MED00006122
LZP    __
$a Pubmed-20150709

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...